Krishna Institute of Medical Sciences Ltd is Rated Sell

Current Rating and Its Implications

MarketsMOJO's 'Sell' rating on Krishna Institute of Medical Sciences Ltd indicates a cautious stance for investors considering this stock. This recommendation suggests that the stock may underperform relative to the broader market or its sector peers in the near to medium term. The rating was revised on 09 December 2025, reflecting a reassessment of the company's prospects based on a comprehensive evaluation of key parameters. Investors should interpret this rating as a signal to carefully analyse the stock's current fundamentals and market position before making investment decisions.

Here's How the Stock Looks Today

As of 05 January 2026, Krishna Institute of Medical Sciences Ltd exhibits a Mojo Score of 35.0, categorised under the 'Sell' grade. This score reflects a decline of 15 points from the previous 50 score when it was rated 'Hold'. The stock's day change stands at +0.98%, with a one-year return of +1.85%, indicating modest gains but underwhelming performance relative to broader market indices and sector averages.

Quality Assessment

The company maintains a 'good' quality grade, signalling that its core business operations and management practices retain a reasonable standard. However, the long-term growth trajectory appears subdued, with operating profit growing at an annualised rate of just 9.36% over the past five years. This growth rate is modest for a hospital sector company, where innovation and expansion often drive higher returns. Additionally, the recent half-year results show a decline in profitability, with PAT contracting by 25.00% and interest expenses rising sharply by 48.09% to ₹77.60 crores, which pressures net earnings and cash flow.

Valuation Considerations

Currently, Krishna Institute of Medical Sciences Ltd is considered 'expensive' based on valuation metrics. The stock trades at an enterprise value to capital employed (EV/CE) ratio of 5.3, which is high relative to its return on capital employed (ROCE) of 10.6%. This disparity suggests that investors are paying a premium for capital employed that is not generating commensurate returns. While the stock is trading at a discount compared to its peers' historical valuations, the elevated valuation relative to current profitability metrics warrants caution. The expensive valuation reduces the margin of safety for investors, especially given the company's recent negative financial trends.

Financial Trend Analysis

The financial trend for Krishna Institute of Medical Sciences Ltd is currently negative. The company reported a return on capital employed (ROCE) of 10.97% in the half-year ended September 2025, which is relatively low and signals diminished efficiency in generating profits from capital. Furthermore, the profit after tax (PAT) has declined by 25.00% in the latest six-month period, while interest costs have surged by 48.09%, indicating rising financial leverage or higher borrowing costs. These factors collectively weigh on the company's earnings quality and cash flow stability, raising concerns about its ability to sustain growth and service debt effectively.

Technical Outlook

From a technical perspective, the stock is rated as 'mildly bearish'. This suggests that recent price movements and chart patterns indicate a cautious or slightly negative momentum. Over the past month and three months, the stock has declined by 9.02% and 7.57% respectively, reflecting some selling pressure. However, the year-to-date return of +5.21% and a one-week gain of +4.13% show intermittent recovery attempts. Investors should monitor technical indicators closely, as the mildly bearish stance implies potential volatility and limited upside in the near term.

Stock Returns and Market Performance

As of 05 January 2026, Krishna Institute of Medical Sciences Ltd has delivered a one-year return of +1.85%, which is modest and underperforms many broader market benchmarks. The stock’s six-month and three-month returns are negative, at -6.97% and -7.57% respectively, indicating recent weakness. Despite a positive one-day change of +0.98% and a one-week gain of +4.13%, the overall trend remains subdued. This performance aligns with the 'Sell' rating, signalling that investors may find better opportunities elsewhere in the hospital sector or broader market.

What This Rating Means for Investors

For investors, the 'Sell' rating on Krishna Institute of Medical Sciences Ltd serves as a cautionary signal. It reflects concerns about the company’s current valuation, financial health, and technical momentum. While the company maintains a reasonable quality grade, the negative financial trends and expensive valuation metrics suggest limited upside potential and increased risk. Investors holding the stock should consider reassessing their positions, especially if their investment horizon is short to medium term. Prospective investors may prefer to explore alternatives with stronger financial trends and more attractive valuations within the hospital sector or broader healthcare space.

Summary

In summary, Krishna Institute of Medical Sciences Ltd’s current 'Sell' rating by MarketsMOJO, updated on 09 December 2025, is grounded in a comprehensive analysis of quality, valuation, financial trends, and technical factors as of 05 January 2026. The company’s modest growth, rising interest costs, declining profitability, and expensive valuation underpin this cautious stance. While the stock has shown some short-term gains, the overall outlook remains subdued, advising investors to approach with prudence and consider portfolio diversification strategies.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →